Amrize (AMRZ) is a Basic Materials company in the Building Materials industry. It has a market capitalization of $22.29B, a trailing price-to-earnings ratio of 18.9 and a free-cash-flow yield of 6.1%. Over the most recent reported fiscal year, revenue grew 0.9% and free cash flow per share fell 13.6%. Nama's AI scorecard rates it Hold, 4.9 out of 10. On 12-month momentum it ranks in the trailing band of its market.
AI scorecard
Hold · 4.9/10
The sections balance. As of Nov 7, 2026.
Momentum
Trailing · -26.8% over 12 months ex. last
Bottom 20% of its market on the past year's move.
Shariah screen
Shariah Compliant
Passes our debt, cash and income screen; not a scholar's ruling.
Off its high
-36.5%
How far the last close sits under the highest price of the past five years.
Market cap
$22.29B
Trailing P/E
18.9
Price / book
1.8
Price / sales
1.8
FCF yield
6.1%
Dividend yield
1.1%
Gross margin
24.8%
Operating margin
15.5%
Net margin
9.9%
Revenue growth (YoY)
+0.9%
Revenue growth (3-yr annual)
+3.3%
EPS growth (YoY)
—
FCF/share growth (YoY)
-13.6%
Beta
—
Exchange
NYSE
Sector
Basic Materials
Industry
Building Materials
AMRZ earnings
Next report: Feb 17, 2027 (Q4 2026, EPS estimate $0.57).
Beat the EPS estimate in 1 of 4 recent quarters.
Quarter
Reported
EPS
Estimate
Surprise
Revenue
Q3 2026
Oct 28, 2026
$1.02
$1.00
+2.0%
$3.77B
Q2 2026
Aug 6, 2026
$0.86
$0.94
-8.5%
$3.49B
Q1 2026
Apr 29, 2026
-$0.21
-$0.15
-40.0%
$2.18B
Q4 2025
Feb 17, 2026
$0.54
$0.64
-15.6%
$2.84B
AMRZ analyst price target
Median target $45.50 from 19 analysts, ranging $32.00 – $55.00.
Nama's AI scorecard currently rates Amrize Hold (4.9 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is AMRZ's P/E ratio?
Amrize trades at a trailing price-to-earnings ratio of 18.9.
When does AMRZ report earnings?
Amrize's next scheduled report is on Feb 17, 2027. Analysts expect EPS of $0.57.
What is the AMRZ price target?
The median analyst price target from 19 analysts is $45.50, with a range of $32.00 – $55.00.
Is AMRZ Shariah compliant?
Nama's AAOIFI-style screen reads Amrize as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.